Conmed Corp risk profile
43 Elevated one input has moved against it
Measured 1 September 2026 from CNMD's filed statements. Recomputed nightly.
43 (Elevated), driven by Operating pressure at 58, over 5 weighted categories on the MANUFACTURER profile.
What is measured
| Mechanism | Reading | Band | Direction | Driver |
|---|---|---|---|---|
| Market expectation | 39 | Normal | Volatile | One-year price volatility — 46.3% |
| Operating pressure | 58 | Elevated | Worsening | Costs outgrowing revenue — +9.8 percentage points |
| Cash conversion | 14 | Contained | Easing | Capital spending against operating cash — 0.12x |
| Leverage and coverage | 48 | Elevated | Worsening | Net debt to EBITDA — 4.50x |
| Competitive position | 43 | Elevated | Stable | R&D-intensity gap against peers — -23.8 percentage points |
| Concentration | Reads identified supplier spend, customers above the 10% disclosure threshold and revenue by region. No reading is stored for this company. | |||
These are descriptive readings of disclosed mechanisms, not investment advice, and not a prediction. A band says where a measured input sits, never what to do about it or what happens next.